期刊文献+

基质金属蛋白酶及其组织抑制因子与肿瘤研究进展 被引量:4

原文传递
导出
摘要 随着对基质金属蛋白酶(MMP)与基质金属蛋白酶组织抑制因子(TIMP)功能和作用机制研究的深人,近年来对MMP和TIMP与肿瘤发生发展的关系有了许多新的认识。MMP的功能远非仅限于降解细胞外基质(ECM)来促进肿瘤的侵袭与转移,而是广泛参与肿瘤发生发展的各个阶段和环节。
作者 姜强 张苏展
出处 《国际肿瘤学杂志》 CAS 2006年第1期18-21,共4页 Journal of International Oncology
  • 相关文献

参考文献30

  • 1Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer ,2002,2 ( 3 ) : 161-174.
  • 2Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer-trials and tribulations. Science,2002,295 (5564) :2387-2392.
  • 3Sternlicht MD, Werb Z. How matrix mctalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol,2001,17 :463-516.
  • 4Lee M, Murphy G. Matrix metalloproteinases at a glance. J Cell Sci,2004,117(18) :4015-4016.
  • 5Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors:biological actions and therapeutic opportunities. J Cell Sci,2002, 115(19) :3719-3727.
  • 6Polette M, Nawrocki Raby B, Gilles C,et al.Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol,2004,49 ( 3 ) : 179-186.
  • 7Tang Y, Kesavan P, Nakada MT, et al. Tumor-stroma interaction:positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase- dependent generation of soluble EMMPRIN. Mol Cancer Res,2004,2(2) :73-80.
  • 8Crawford HC, Fingleton B, Gustavson MD, et al. The PEA3 subfamily of Ets transcription factors synergizes with 13-Catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol,2001,21(4) :1370-1383.
  • 9Zhou Y, Yu C, Miao X, et al. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2genes. Carcinogenesis ,2004 ,25 ( 3 ) : 399-404.
  • 10Hotary KB, Allen ED, Brooks PC, et al. Membrane type Ⅰ matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell,2003,114(1) :33-45.

同被引文献51

  • 1于学燕,王永刚.基质金属蛋白酶及其抑制剂与肺癌的侵袭和转移[J].癌症进展,2005,3(4):374-377. 被引量:3
  • 2吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 3倪培华,应雅韵,张洁,金磊.肝脂酶启动子250 G/A多态性与血脂的关系[J].检验医学,2005,20(6):565-570. 被引量:16
  • 4Simi L, Andreani M, Davini F. Simultaneous measurement of MMP-9 and TIMP-1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. Lung Cancer,2004,45(2) :171-179.
  • 5Mihaylova Zh, Ludovini V, Gregorg V, et al. Serum level changes of matrix metalloproteinases :2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients. J BUON,2007,12 ( 1 ) : 105-111.
  • 6Pinto CA, Carvalho PE, Antonangelo L. Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung. Clin Cancer Res, 2003,9 ( 8 ) : 3098- 3104.
  • 7L iotta LA, Stetler Stevenson MG. Tumor invasion and metastasis : an imbalance of positive and negative regulation [ J ]. Cancer Res, 1991,51 (suppl) :5054 - 5059.
  • 8Chamber AF, Matfisian LM. Changing views of matrix metallo- proteinase in metastasis [ J ]. Natl Cancer Inst, 1997,89 ( 6 ) : 1260 - 1265.
  • 9Parsons SL, Watson SA, ollins HM, et al. Gelatinase( MMP - 2 and MMP - 9 ) expression in gastrointestinal malignancy [ J ]. Br J Cancer, 1998,78 ( 11 ) : 1459 - 1502.
  • 10宋明志,刘鲁明.于尔辛肝癌经验集[M].北京:人民卫生出版社,2004.30

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部